Author:
Wen Lv,Hong Ding,Yanyin Wu,Mingyue Zhang,Baohua Li
Publisher
Springer Science and Business Media LLC
Subject
Obstetrics and Gynecology,General Medicine
Reference24 articles.
1. Jemal A, Siegel R, Ward E et al (2009) Cancer statistics, 2009. CA Cancer J Clin 59:225–249
2. Chen J, Yang R, Liu F (2000) Establishment of cisplatin-induced multidrug resistant human epithelial ovarian cancer cell line 3AO/cDDP and its expressions of multidrug resistance proteins. Zhonghua Fu Chan Ke Za Zhi 35:617–620
3. Selvakumaran M, Pisarcik DA, Bao R et al (2003) Enhanced cisplatin cytotoxicity by disturbing the nucleotide excision repair pathway in ovarian cancer cell lines. Cancer Res 63:1311–1316
4. Chock KL, Allison JM, Shimizu Y et al (2010) BRCA1-IRIS overexpression promotes cisplatin resistance in ovarian cancer cells. Cancer Res 70:8782–8791
5. Schildkraut JM, Calingaert B, Marchbanks PA et al (2002) Impact of progestin and estrogen potency in oral contraceptives on ovarian cancer risk. J Natl Cancer Inst 94:32–38
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献